These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4379937)

  • 21. Monoamine oxidase inhibition and recovery in the mouse brain at various ages after birth.
    Samsa JM; Baker PC; Hoff KM
    Biol Neonate; 1979; 35(5-6):249-54. PubMed ID: 476197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
    Fagervall I; Ross SB
    Biochem Pharmacol; 1986 Apr; 35(8):1381-7. PubMed ID: 2870717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J; Kattau R; Slater IH; Fuller RW
    J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR; Boulton AA
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract]   [Full Text] [Related]  

  • 25. Monoamine oxidase in man: enzyme characteristics in platelets, plasma, and other human tissues.
    Murphy DL; Donnelly CH
    Adv Biochem Psychopharmacol; 1974; 12(0):71-85. PubMed ID: 4607554
    [No Abstract]   [Full Text] [Related]  

  • 26. [Excitormotor effects of tryptamine, in presence of IMAO, in mice pretreated with enzymatic inducers].
    Denys A; Levy J; Michel-Ber E
    Therapie; 1969; 24(5):907-22. PubMed ID: 4391432
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of monoamine oxidase inhibitors of various chemical nature on some indices of carbohydrate metabolism in the rabbit brain].
    Musialkovskaia AA
    Ukr Biokhim Zh; 1967; 39(2):119-24. PubMed ID: 5603054
    [No Abstract]   [Full Text] [Related]  

  • 28. Proceedings: Age dependent recovery of rat brain MAO activity after administration of a single dose of iproniazid and pargyline.
    Sprengeler T; Rakow D; Schulze G; Christ W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R12. PubMed ID: 1143390
    [No Abstract]   [Full Text] [Related]  

  • 29. Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
    Javoy F; Youdim MB; Agid Y; Glowinski J
    J Neural Transm; 1973; 34(4):279-89. PubMed ID: 4149516
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 31. Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors.
    Aghajanian GK; Graham AW; Sheard MH
    Science; 1970 Sep; 169(3950):1100-2. PubMed ID: 5449322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Special application of fluorescence histochemistry: studies on eight monoamine oxidase inhibitors in brain neurons.
    Bartonícek VJ
    Pharmacology; 1970; 4(1):16-24. PubMed ID: 4393462
    [No Abstract]   [Full Text] [Related]  

  • 33. Antagonism between stereoisomeric amphetamines, amphetamine derivatives and other monoamine oxidase inhibitors.
    Parmar SS
    Biochem Pharmacol; 1966 Oct; 15(10):1497-505. PubMed ID: 4382014
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of monoamine oxidase inhibitors on the N-demethylation and hydrolysis of meperidine.
    Eade NR; Renton KW
    Biochem Pharmacol; 1970 Jul; 19(7):2243-50. PubMed ID: 5520372
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of the in vivo inhibition of brain and liver monoamine oxidase as produced by beta-phenylisopropylhydrazine (PIH) and iproniazid.
    GOGERTY JH; HORITA A
    J Pharmacol Exp Ther; 1960 Aug; 129():357-60. PubMed ID: 13850477
    [No Abstract]   [Full Text] [Related]  

  • 36. The value of histochemical demonstration of monoamine oxidase in experimental pharmacology and its correlation with biochemical determination of monoamine oxidase activity.
    Meier-Ruge W; McFadden S; Zehnder K
    Med Pharmacol Exp Int J Exp Med; 1966; 14(2):152-60. PubMed ID: 5952033
    [No Abstract]   [Full Text] [Related]  

  • 37. The binding of [3H] pargyline to rat liver mitochondrial monoamine oxidase.
    Parkinson D; Callingham BA
    J Pharm Pharmacol; 1980 Jan; 32(1):49-54. PubMed ID: 6102127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in tissue levels of S-adenosylmethionine.
    Baldessarini RJ
    Biochem Pharmacol; 1966 Jun; 15(6):741-8. PubMed ID: 4381472
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 40. Interactions between monoamine oxidase inhibitors and sympathomimetic amines in the rat isolated vas deferens.
    Laporte J; Jané F; Valdecasas FG
    J Pharm Pharmacol; 1968 Feb; 20(2):148-9. PubMed ID: 4384539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.